Skip to main content

Advertisement

SpringerLink
Log in

Indication of Immune Activation in Patients with Perceived Food Hypersensitivity

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Majority of the patients with perceived food hypersensitivity have irritable bowel syndrome (IBS), and a significant proportion of IBS patients also attribute their gastrointestinal complaints to food items. Different factors such as disturbed intestinal fermentation, enteric dysmotility, post-infectious changes and altered microbial flora in the colon as well as psychological disturbances likely play a role in the pathophysiology and symptoms generation in patients with food hypersensitivity. In addition, a number of studies in these patient groups indicate that local, systemic and mucosal immune systems are activated. The question now is no longer intestinal immune activation, but how the immune system is activated in these patients. In the following review, the potential pathogenetic role of the immune system and evidence of immune activation are reported in patients with perceived food hypersensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Rona RJ, Keil T, Summers C, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol. 2007;120:638–646.

    Article  PubMed  Google Scholar 

  2. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome: etiology, prevalence and consequences. Eur J Clin Nutr. 2006;60:667–672.

    Article  CAS  PubMed  Google Scholar 

  3. Soares RL, Figueiredo HN, Maneschy CP, Rocha VR, Santos JM. Correlation between symptoms of the irritable bowel syndrome and the response to the food extract skin prick test. Braz J Med Biol Res. 2004;37:659–662.

    CAS  PubMed  Google Scholar 

  4. Lied GA, Lillestøl K, Lind R, et al. Perceived food hypersensitivity: a review of 10 years of interdisciplinary research at a reference centre. Scand J Gastroenterol. 2011;46:1169–1178.

    Article  PubMed  Google Scholar 

  5. Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006;18:595–607.

    Article  PubMed  Google Scholar 

  6. Barbara G, Zecchi L, Barbaro R, et al. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. J Clin Gastroenterol. 2012;46:52–55.

    Article  Google Scholar 

  7. Perrier C, Corthesy B. Gut permeability and food allergies. Clin Exp Allergy. 2011;41:20–28.

    Article  CAS  PubMed  Google Scholar 

  8. Macdonald TT, Monteleone G. Immunity, inflammation and allergy in the gut. Science. 2005;307:616–623.

    Article  Google Scholar 

  9. Su L, Shen L, Clayburgh DR, et al. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology. 2009;136:551–563.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799–809.

    Article  CAS  PubMed  Google Scholar 

  11. Berstad A, Arslan G, Folvik G. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scand J Gastroenterol. 2000;35:64–69.

    Article  CAS  PubMed  Google Scholar 

  12. Iqbal TH, Lewis KO, Cooper BT. Diffusion of polyethylene glycol.400 across lipid barriers in vitro. Clin Sci. 1993;85:111–115.

    CAS  PubMed  Google Scholar 

  13. Schrander JJ, Unsalan-Hooyen RW, Forget PP, Jansen J. [51Cr] EDTA intestinal permeability in children with cow’s milk intolerance. J Pediatr Gastroenterol Nutr. 1990;10:189–192.

    Article  CAS  PubMed  Google Scholar 

  14. Falth-Magnusson K, Kjellman NI, Odelram H, Sundqvist T, Magnusson KE. Gastrointestinal permeability in children with cow’s milk allergy: effect of milk challenge and sodium cromoglycate as assessed with polyethyleneglycols (PEG 400 and PEG 1000). Clin Allergy. 1986;16:543–551.

    Article  CAS  PubMed  Google Scholar 

  15. Jalonen T. Identical intestinal permeability changes in children with different clinical manifestations of cow’s milk allergy. J Allergy Clin Immunol. 1991;88:737–742.

    Article  CAS  PubMed  Google Scholar 

  16. Ventura MT, Polimeno L, Amoruso AC, et al. Intestinal permeability in patients with adverse reactions to food. Dig Liv Dis. 2006;38:732–736.

    Article  CAS  Google Scholar 

  17. Lillestøl K, Helgeland L, Helgeland L, Arslan Lied G, et al. Indications of “atopic bowel” in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther. 2010;31:1112–1122.

    PubMed  Google Scholar 

  18. Piche T, Barbara G, Aubert P, et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut. 2009;58:196–201.

    Article  CAS  PubMed  Google Scholar 

  19. Martinez C, Vicario M, Ramos L, et al. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol. 2012;107:736–746.

    Article  CAS  PubMed  Google Scholar 

  20. Coeffier M, Gloro R, Boukhettala N, et al. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am J Gastroenterol. 2010;105:1181–1188.

    Article  CAS  PubMed  Google Scholar 

  21. Bengtsson U, Knutson TW, Knutson L, Dannaeus A, Hallgren R, Ahlstedt S. Eosinophil cationic protein and histamine after intestinal challenge in patients with cow’s milk intolerance. J Allergy Clin Immunol. 1997;100:216–221.

    Article  CAS  PubMed  Google Scholar 

  22. Bischoff SC, Mayer J, Wedemeyer J, et al. Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy. Gut. 1997;40:745–753.

    Article  CAS  PubMed  Google Scholar 

  23. Bischoff SC, Grabowsky J, Manns MP. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci. 1997;42:394–403.

    Article  CAS  PubMed  Google Scholar 

  24. Bischoff SC, Mayer J, Nguyen QT, Stolte M, Manns MP. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol. 1999;94:3521–3529.

    Article  CAS  PubMed  Google Scholar 

  25. Kosa L, Kereki E, Borzsonyl L. Copro-eosinophil cationic protein (ECP) in food allergy. Allergy. 1996;51:9.

    Article  Google Scholar 

  26. Bischoff SC, Mayer J, Meier PN, Zeck-Kapp G, Manns MP. Clinical significance of the colonoscopic allergen provocation test. Int Arch Allergy Immunol. 1997;113:348–351.

    Article  CAS  PubMed  Google Scholar 

  27. Weidenhiller M, Trankner A, Schwab D, Winterkamp S, Hahn EG, Raithel M. Different kinetics of mediator release can be detected during allergic reactions after oral provocation (double blind placebo-controlled food challenge). Inflamm Res. 2002;51:S29–S30.

    CAS  PubMed  Google Scholar 

  28. Winterkamp S, Weidenhiller M, Wilken V, et al. Standardised evaluation of urinary excretion of N-tele-methylhistamine in different periods of age in a healthy population. Inflamm Res. 2003;52:S57–S58.

    Article  CAS  PubMed  Google Scholar 

  29. Kumlin M. Measurement of leukotrienes in humans. Am J Respir Crit Care Med. 2000;161:S102–S106.

    Article  CAS  PubMed  Google Scholar 

  30. Andre F, Pene J, Andre C. Interleukin-4 and interferon-gamma production by peripheral blood mononuclear cells from food-allergic patients. Allergy. 1996;51:350–355.

    CAS  PubMed  Google Scholar 

  31. Hauer AC, Breese EJ, Walker-Smith JA, MacDonald TT. The frequency of cells secreting interferon-gamma and interleukin-4, -5, and -10 in the blood and duodenal mucosa of children with cow’s milk hypersensitivity. Pediatr Res. 1997;42:629–638.

    Article  CAS  PubMed  Google Scholar 

  32. Kondo N, Fukutomi O, Agata H, et al. The role of T lymphocytes in patients with food-sensitive atopic dermatitis. J Allergy Clin Immunol. 1993;91:658–668.

    Article  CAS  PubMed  Google Scholar 

  33. Öhman L, Isakson S, Lindmark AC, et al. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol. 2009;104:1205–1212.

    Article  PubMed  Google Scholar 

  34. O’Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541–551.

    Article  PubMed  Google Scholar 

  35. Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009;104:392–400.

    Article  CAS  PubMed  Google Scholar 

  36. Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood. 2006;108:1435–1440.

    Article  CAS  PubMed  Google Scholar 

  37. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002;23:445–449.

    Article  CAS  PubMed  Google Scholar 

  38. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284:1835–1837.

    Article  CAS  PubMed  Google Scholar 

  39. Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy and immunotherapy: implications for future treatment. J Allergy Clin Immunol. 2008;121:1344–1350.

    Article  CAS  PubMed  Google Scholar 

  40. Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol. 2005;115:3–1112.

    Article  PubMed  Google Scholar 

  41. Chadwick VS, Chen WX, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122:1778–1783.

    Article  PubMed  Google Scholar 

  42. Ohman L, Lindmark AC, Isaksson S, et al. B-cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2009;21:644–650.

    Article  CAS  PubMed  Google Scholar 

  43. Lied GA, Vogelsang P, Berstad A, Appel S. Dendritic cell populations in patients with self-reported food hypersensitivity. Int J Gen Med. 2011;4:389–396.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Immunology. 2002;2:465–475.

    CAS  PubMed  Google Scholar 

  45. Lied GA, Berstad A. Functional and clinical aspects of the B-cell activating factor (BAFF): a narrative review. Scand J Immunol. 2011;73:1–7.

    Article  CAS  PubMed  Google Scholar 

  46. Lied GA, Lillestøl K, Valeur J, Berstad A. Intestinal B cell-activating factor (BAFF): an indicator of non-IgE-mediated hypersensitivity reactions to food? Aliment Pharmacol Ther. 2010;32:66–73.

    Article  CAS  PubMed  Google Scholar 

  47. Santos J, Bayarri C, Saperas E, et al. Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy. Gut. 1999;45:553–558.

    Article  CAS  PubMed  Google Scholar 

  48. Arslan G, Ødegaard S, Elsayed S, Florvaag E, Berstad A. Food allergy and intolerance: response to intestinal provocation monitored by endosonography. Eur J Ultrasound. 2002;15:29–36.

    Article  PubMed  Google Scholar 

  49. Arslan G, Gilja OH, Lind R, Florvaag E, Berstad A. Response to intestinal provocation monitored by transabdominal ultrasound in patients with food hypersensitivity. Scand J Gastroenterol. 2005;40:386–394.

    Article  PubMed  Google Scholar 

  50. Arslan G, Lillestøl K, Mulahasanovic A, Florvaag E, Berstad A. Food hypersensitivity reactions visualised by ultrasonography and magnetic resonance imaging in a patient lacking systemic food-specific IgE. Digestion. 2006;73:111–115.

    Article  PubMed  Google Scholar 

  51. Lin XP, Magnusson J, Ahlstedt S, et al. Local allergic reaction in food-hypersensitive adults despite a lack of systemic food-specific IgE. J Allergy Clin Immunol. 2002;109:879–887.

    Article  PubMed  Google Scholar 

  52. Crowe SE, Perdue MH. Gastrointestinal food hypersensitivity: basic mechanisms of pathophysiology. Gastroenterology. 1992;103:1075–1095.

    CAS  PubMed  Google Scholar 

  53. Arslan G, Kahrs GE, Lind R, Frøyland L, Florvaag E, Berstad A. Patients with subjective food hypersensitivity: the value of analysing intestinal permeability and inflammation markers in gut lavage fluid. Digestion. 2004;70:26–35.

    Article  CAS  PubMed  Google Scholar 

  54. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77:1033–1079.

    CAS  PubMed  Google Scholar 

  55. Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 1996;28:1–13.

    Article  CAS  PubMed  Google Scholar 

  56. Galli SJ. New insights into “the riddle of the mast cells”: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest. 1990;62:5–33.

    CAS  PubMed  Google Scholar 

  57. Irani AM, Schwartz LB. Mast cell heterogeneity. Clin Exp Allergy. 1989;19:143–155.

    Article  CAS  PubMed  Google Scholar 

  58. Rydning A, Lyng O, Falkmer S, Gronbech JE. Histamine is involved in gastric vasodilation during acid back diffusion via activation of sensory neurons. Am J Physiol Gastrointest Liver Physiol. 2002;283:G603–G611.

    CAS  PubMed  Google Scholar 

  59. Pothoulakis C, Castagliuolo I, LaMont JT. Nerves and intestinal mast cells modulate responses to enterotoxins. News Physiol Sci. 1998;13:58–63.

    CAS  PubMed  Google Scholar 

  60. Holzer P, Guth PH. Neuropeptide control of rat gastric mucosal blood flow. Increase by calcitonin gene-related peptide and vasoactive intestinal polypeptide, but not substance P and neurokinin A. Circ Res. 1991;68:100–105.

    Article  CAS  PubMed  Google Scholar 

  61. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.

    Article  PubMed  Google Scholar 

  62. Shea-Donohue T, Stiltz J, Zhao A, Notari L. Mast cells. Curr Gastroenterol Rep. 2010;12:349–357.

    Article  PubMed Central  PubMed  Google Scholar 

  63. Yu LC. The epithelial gatekeeper against food allergy. Pediatr Neonatol. 2009;50:247–254.

    Article  PubMed  Google Scholar 

  64. He S, Zhang H, Chen H, et al. Expression and release of IL-29 by mast cells and modulation of mast cell behavior by IL-29. Allergy. 2010;65:1234–1241.

    Article  CAS  PubMed  Google Scholar 

  65. Castellani ML, Kempuraj D, Salini V, et al. The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator. J Biol Regul Homeost Agents. 2009;23:11–14.

    CAS  PubMed  Google Scholar 

  66. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010;10:103–110.

    Article  CAS  PubMed  Google Scholar 

  67. Forbes EE, Groschwitz K, Abonia JP, et al. IL-9—and mast cell mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med. 2008;205:897–913.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  68. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut. 2002;51:i41–i44.

    Article  PubMed  Google Scholar 

  69. Lee KJ, Kim YB, Kim JH, et al. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol. 2008;23:1689–1694.

    Article  PubMed  Google Scholar 

  70. Guilarte M, Santos J, de Torres I, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56:203–209.

    Article  PubMed  Google Scholar 

  71. Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009;29:765–773.

    Article  CAS  PubMed  Google Scholar 

  72. McKernan DP, Gaszner G, Quigley EM, Cryan JF, Dinan TG. Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Alim Pharmacol Ther. 2011;33:1045–1052.

    Article  CAS  Google Scholar 

  73. Belmonte L, Youmba SB, Bertiaux-Vandaele N, et al. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the diseases subtype. PLoS One. 2012;7:e42777.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  74. Barbara G, Cremon C, Carini G, et al. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349–359.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Chassard C, Dapoigny M, Scott KP, et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther. 2012;35:828–838.

    Article  CAS  PubMed  Google Scholar 

  76. Bonfrate L, Tack J, Grattagliano I, Cuomo R, Portincasa P. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol. 2013;48:995–1009.

    Article  PubMed  Google Scholar 

  77. Bourdu S, Dapoigny M, Chapuy E, et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology. 2005;128:1996–2008.

    Article  CAS  PubMed  Google Scholar 

  78. Dahlqvist G, Piessevaux H. Irritable bowel syndrome: the role of the intestinal microbiota, pathogenesis and therapeutic targets. Acta Gastroenterol Belg. 2011;74:375–380.

    CAS  PubMed  Google Scholar 

  79. Fremont M, Coomans D, Massart S, De Meirleir K. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients. Anaerobe. 2013;22:50–56.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Clinical Medicine, University of Bergen, Bergen, Norway

    Gülen Arslan Lied

  2. Division of Gastroenterology, Department of Medicine, Haukeland University Hospital, 5021, Bergen, Norway

    Gülen Arslan Lied

Authors
  1. Gülen Arslan Lied
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gülen Arslan Lied.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lied, G.A. Indication of Immune Activation in Patients with Perceived Food Hypersensitivity. Dig Dis Sci 59, 259–266 (2014). https://doi.org/10.1007/s10620-013-2926-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2926-0

Keywords

Search

Navigation